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Disseminated BCG Infection 
in a patient with Severe Combined
Immunodeficiency
Disseminated mycobacterial infection after bacillus Calmette-Guerin (BCG)
vaccination is a very rare disorder, occurring mostly in patients with immunologic
deficiency. We report a case of disseminated BCG infection in a 16-month-old girl
with severe combined immunodeficiency. Plain radiographs showed multiple
osteolytic lesions in the femora, tibiae, humerus, and phalanges. Abdominal
sonography and CT scanning revealed multiple nodules in the spleen, and porto-
caval lymphadenopathy. 
mmunization of children with bacillus Calmette-Guerin (BCG), a live at-
tenuated bacterial vaccine derived from Mycobacterium bovis, is recom-
mended by the World Health Organization in communities with a high
prevalence of tuberculosis. BCG vaccines are extremely safe in immunocompetent
hosts, but possible complications range from local inflammatory reactions (lym-
phadenitis, abscess, fistula formation) to disseminated diseases (osteomyelitis, bac-
teremia, meningitis) and death (1). Significant local reactions occur in 0.1-1% of vac-
cine recipients, whereas serious disseminated BCG infection occurs very rarely, in few-
er than one in a million cases (2). The disseminated form of tuberculosis, which has a
high mortality rate, develops mostly in patients with immunologic deficiency (3).
Radiological reports of disseminated BCG infection have focused mainly on os-
teomyelitis (3 5). We described the radiological manifestations of disseminated BCG
infection in an infant with severe combined immunodeficiency. 
CASE REPORT
A 7-month-old girl presented with a prolonged period of chronic diarrhea. On ad-
mission she showed profound abnormalities in both cell-mediated and humoral immu-
nities and severe combined immunodeficiency was diagnosed. Laboratory values were
as follows: immunoglobulin (IgG), 173 mg/dL (normal range, 500 1300 mg/dL); IgM,
31 mg/dl (normal range, 50 199 mg/dL); IgA, 29 mg/dL (normal range, 23 190
ml/dL); T2/ T4/ T8 /B cell /Natural Killer (NK) cell, 4% / 4% / 0% / 2% / 90%. 
At the age of 10 months she was readmitted due to left axillary and cervical lym-
phadenopathy; several courses of antibiotic treatment had failed to change the course
of her illness. There was no family history of tuberculosis, but she had been vaccinated
with BCG at the age of one month. A specimen for culture was obtained from the axil-
lary lymph node, but bacteriological culture was negative. Numerous acid-fast bacilli
were demonstrated on smears, and cultures revealed growth of Mycobacterium bovis,
BCG strain. She was treated with isoniazid (15 mg/kg per day), rifampicin (15 mg/kg
per day), and pyrazinamide (20 mg/kg per day). In spite of antituberculous therapy,
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Fig. 1. Disseminated BCG infection in a 16-month-old girl with severe combined immunodeficiency. 
A. Plain radiograph of both lower extremities reveals multiple, round, osteolytic lesions in the distal femora, tibiae, and fibulas. Both tibiae
show extensive periosteal thickening along the entire diaphyses. Osteolytic lesions extend into the thickened periosteum (arrows).
B. Transverse sonogram through the upper abdomen shows enlarged lymph nodes containing eccentric hypoechoic portion (arrow) at
the porta hepatis.
C. Longitudinal us scan of the spleen reveals hypoechoic nodules (arrows).
D. Contrast enhanced CT scan shows multiple, round, hypodense nodules in the spleen. The presence of portocaval lymphadenopathy,
with a central low attenuated area (arrow), should also be noted.
AB
CDher lymphadenopathy worsened. 
At the age of 16 months, she was readmitted with persis-
tent lymphadenopathy in the left axilla and cervical area,
and reddish swelling of the right third finger. A chest radi-
ograph revealed no abnormality of lung parenchyma or hi-
lar lymphadenopathy, but a round osteolytic lesion was in-
cidentally detected in the right distal humerus. A plain ra-
diograph of both lower extremities revealed multiple,
round, osteolytic lesions in the femora, tibiae, and fibulas
(Fig. 1A). Both tibiae showed extensive periosteal thicken-
ing along the entire diaphyses. Ultrasound examination of
the abdomen showed enlarged lymph nodes containing an
eccentric hypoechoic portion at the porta hepatis and hy-
poechoic nodules in the spleen (Figs. 1B,C). Contrast-en-
hanced CT scanning demonstrated the presence of multiple
nodules in the spleen, and portocaval lymphadenopathy
with a central low-attenuated area (Fig. 1D). 
DISCUSSION
BCG is a live attenuated bacterial vaccine for infants
born in countries with a high incidence of Mycobacterium
tuberculosis infection, and protects children from miliary
tuberculosis and tuberculous meningitis. It is considered a
safe vaccine with a low incidence of complications, the
overall rate of which has been estimated to be 1% or less
(6). The incidence of complications, however, has varied
according to the vaccine strain, dosage, and method of ad-
ministration. The most frequent complications are local in-
flammatory reactions, including hypersensitivity, localized
lymphadenitis, and local abscess or fistula formation. 
Disseminated disease, the most serious complication of
BCG vaccination, develops in less than one case in a mil-
lion. Disseminated BCG infections have occurred following
vaccination of children with immunodeficiency disorders
such as severe combined immunodeficiency, chronic gran-
ulomatous disease, complete Di George syndrome, AIDS,
HIV infection or idiopathic immunodeficiency of genetic
origin, but only rarely in apparently normal individuals (6).
Severe combined immunodeficiency, as in this case, usual-
ly presents in infancy, with severe infections, and is charac-
terized clinically and immunologically by profound abnor-
malities of cell-mediated and humoral immunities. Infants
with immunodeficiency contraindicate BCG vaccination,
but are usually vaccinated prior to diagnosis. In other cas-
es, immunodeficiency may be diagnosed after the develop-
ment of BCG complications. Our patient was vaccinated
with BCG before severe combined immunodeficiency was
diagnosed. Subsequently, to prevent BCG complications,
her younger brother was not vaccinated.
Disseminated BCG infection may involve the bones,
joints, liver, spleen, and lymph nodes, and is usually fatal.
Tuberculous osteomyelitis in infants and young children
usually develops after BCG vaccination, and its frequency
is assumed to be approximately one case per million vacci-
nations (7). Bone changes generally appear between three
months and five years after vaccination. BCG osteomyelitis
involves the hand, foot, long bone, spine, rib, sternum, and
clavicle, the tubular bones of the fingers and toes being the
most common sites of involvement (4). BCG osteomyelitis
generally occurs in the metaphysis or epiphysis of the long
bones or bones of the fingers and toes. In immunocompe-
tent children, a solitary lesion with a sclerotic margin usual-
ly appears (5), whereas in children with immunodeficiency
disorders there is multiple involvement. Hugosson et al. (3)
reported a case of extensive disseminated skeletal os-
teomyelitis in a 9-month-old female infant with severe com-
bined immunodeficiency. The bone lesions were mainly lo-
cated in the metaphysis of the distal parts of the femora,
proximal parts of the tibiae, both proximal humeral shafts,
the ribs and skull, and no cortical thickening was observed.
In our case, the involved bones were similar, except for the
rib and skull, but the lesions were mainly in diaphyseal lo-
cations of the long bones, with diffuse cortical thickening. 
The differential diagnoses of multiple osteolytic bone le-
sions in infants include metastatic neuroblastoma,
leukemia, osteomyelitis, and Langerhans cell histiocytosis.
Metastatic neuroblastoma and leukemia may have a simi-
lar radiographic appearance, demonstrating permeative or
moth-eaten destruction and periosteal new-bone forma-
tion. Pyogenic osteomyelitis shows permeative bone de-
struction, and mainly involves the metaphysis. Langerhans
cell histiocytosis may destroy or expand the cortex, and
overlying periosteal new-bone formation is usually pre-
sent, though in patients with this condition, compact pe-
riosteal reaction is also a typical feature (8). 
Disseminated BCG infection in patients with severe com-
bined immunodeficiency may also involve the lung, liver,
spleen, and lymph nodes. In our case, the spleen and
lymph nodes at the porta hepatis were also involved. US
and CT scans of enlarged lymph nodes at the porta hepatis
revealed the presence of central low echogenic or low at-
tenuating lesions, which were thought to be areas of
caseation necrosis. Demonstration of low echogenic or low
attenuating areas within the enlarged lymph nodes, as
demonstrated by CT scanning and ultrasound, may be
helpful in the diagnosis of tuberculosis. 
In summary, disseminated BCG infection in our patient
with severe combined immunodeficiency led not only to
disseminated osteomyelitis but also lymphadenitis and vis-
ceral organ involvement. 
Han et al.
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